Emergency Contraception

• CLINICAL_TRIALS research · 2025-04-24
  Clinical Trial Update: Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo [Phase 4]

  A Phase 4 clinical trial evaluating the insertion of an etonogestrel implant for emergency contraception in combination with oral levonorges…

• CLINICAL_TRIALS trial_result · 2022-12-02
  Clinical Trial Update: A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions [Phase 3]

  Phase 3 trial update for Ella® emergency contraceptive under simulated OTC conditions; results posted in 2022.

• CLINICAL_TRIALS trial_result · 2021-05-03
  Clinical Trial Update: Safety and Efficacy of CDB-2914 for Emergency Contraception [Phase 3]

  Phase 3 trial update on safety and efficacy of CDB-2914 for emergency contraception; results posted after completion.

• CLINICAL_TRIALS research · 2019-10-21
  Clinical Trial Update: Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella

  Clinical trial follow-up and outcomes of pregnancies exposed to Ella (emergency contraception) has completed with results posted.

• FDA approval · 2016-09-13
  FDA Approved: OPTIONELLE — Supplemental Application (Strides Pharma Inc)

  The FDA approved a supplemental application for OPTIONELLE (levonorgestrel tablet, 1.5 mg) from Strides Pharma Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-08-23
  FDA Approved: AMAZON BASIC CARE LEVONORGESTREL — Supplemental Application (Amazon.com Services LLC)

  FDA approved a supplemental application for Amazon Basic Care Levonorgestrel (levonorgestrel), a generic contraceptive product manufactured …

• FDA approval · 2015-05-29
  FDA Approved: OPTIONELLE — Original Application (Strides Pharma Inc)

  The FDA approved OPTIONELLE (levonorgestrel tablet, 1.5 mg) from Strides Pharma Inc as an original application generic for emergency contrac…

• FDA approval · 2014-06-27
  FDA Approved: ELLA — Supplemental Application (HRA PHARMA AMERICA, INC.)

  FDA approved a supplemental application for Ella (ulipristal acetate) submitted by HRA Pharma America, Inc.

• FDA approval · 2013-06-20
  FDA Approved: PLAN B ONE-STEP — Supplemental Application (Foundation Consumer Healthcare LLC)

  The FDA approved a supplemental application for Plan B One-Step (levonorgestrel) filed by Foundation Consumer Healthcare LLC.

• CLINICAL_TRIALS trial_result · 2007-12-17
  Clinical Trial Update: Efficacy Trial of CDB 2914 for Emergency Contraception [Phase 2, Phase 3]

  This update announces the completion of a Phase 2/3 efficacy trial of CDB 2914 for emergency contraception.